Error quantification in multi-parameter mapping facilitates robust estimation and enhanced group level sensitivity.

Error propagation Multi-parameter mapping Quantitative MRI Robust estimate Signal-to-noise ratio

Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
15 11 2022
Historique:
received: 29 12 2021
revised: 20 07 2022
accepted: 01 08 2022
pubmed: 5 8 2022
medline: 14 9 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

Multi-Parameter Mapping (MPM) is a comprehensive quantitative neuroimaging protocol that enables estimation of four physical parameters (longitudinal and effective transverse relaxation rates R

Identifiants

pubmed: 35926761
pii: S1053-8119(22)00644-9
doi: 10.1016/j.neuroimage.2022.119529
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

119529

Subventions

Organisme : Medical Research Council
ID : MR/R000050/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203147/Z/16/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The Max Planck Institute for Human Cognitive and Brain Sciences has an institutional research agreement with Siemens Healthcare. NW holds a patent on acquisition of MRI data during spoiler gradients (US 10,401,453 B2). NW was a speaker at an event organized by Siemens Healthcare and was reimbursed for the travel expenses.

Auteurs

Siawoosh Mohammadi (S)

Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. Electronic address: s.mohammadi@uke.de.

Tobias Streubel (T)

Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Leonie Klock (L)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Luke J Edwards (LJ)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Antoine Lutti (A)

Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Kerrin J Pine (KJ)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Sandra Weber (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Patrick Scheibe (P)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Gabriel Ziegler (G)

Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Germany; Germany Weierstrass Institute for Applied Analysis and Stochastics, German Center for Neurodegenerative Diseases, Magdeburg, Berlin, Germany.

Jürgen Gallinat (J)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Simone Kühn (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Max Planck Institute for Human Development, Lise Meitner Group for Environmental Neuroscience, Berlin, Germany.

Martina F Callaghan (MF)

Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, UCL, London, UK.

Nikolaus Weiskopf (N)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany; Felix Bloch Institute for Solid State Physics, Leipzig University, Linnéstraße 5, Leipzig 04103, Germany.

Karsten Tabelow (K)

Weierstrass Institute for Applied Analysis and Stochastics, Mohrenstrasse 39, Berlin 10117, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH